- Home
- GIB vs ASND Comparison
GIB vs ASND Comparison
Compare GIB & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GIB | ASND |
|---|---|---|
| Founded | 1976 | 2006 |
| Country | Canada | Denmark |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.0B | 13.6B |
| IPO Year | 1999 | 2014 |
Fundamental Metrics
Financial Performance| Metric | GIB | ASND |
|---|---|---|
| Price | $71.05 | $216.62 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 16 |
| Target Price | $117.00 | ★ $279.50 |
| AVG Volume (30 Days) | 352.1K | ★ 529.3K |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.63% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.33 | $98.57 |
| Revenue Next Year | $2.96 | $43.22 |
| P/E Ratio | $13.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $69.96 | $124.06 |
| 52 Week High | $110.07 | $248.60 |
Technical Indicators
Market Signals| Indicator | GIB | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 37.85 | 40.63 |
| Support Level | $69.96 | $190.49 |
| Resistance Level | $76.22 | $218.88 |
| Average True Range (ATR) | 1.58 | 7.96 |
| MACD | 0.31 | -1.82 |
| Stochastic Oscillator | 3.53 | 15.41 |
Price Performance
Historical ComparisonAbout GIB CGI Inc.
CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company is one of the major IT suppliers to different levels of government around the world. It offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services to governments and the private sector. With offices in over 40 countries, CGI follows a balanced global delivery model with most consultants in client proximity.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.